Swedish wariness over Pfizer bid for AstraZeneca rooted in past

[at Financial Times] – After a slow start, public figures in Sweden – the other home market for AstraZeneca besides the UK – are starting to speak out against Pfizer’s $110bn bid for the Anglo-Swedish drugmaker. Politicians … more

View todays social media effects on PFE

View the latest stocks trending across Twitter. Click to view dashboard

See who Pfizer is hiring next, click here to view